Thank you for selecting our 𝐂𝐎𝐏𝐃 PPT
This medical PowerPoint template about 𝐂𝐎𝐏𝐃
You can download our template by visiting our website:
https://www.rxslides.com/product/copd-powerpoint-template
copy and paste this URL into the browser and download the full editable template.
This 𝐂𝐎𝐏𝐃 animated template is designed by RxSlides, a medical professional team covering the following topics about 𝐂𝐎𝐏𝐃
𝐓𝐡𝐞 𝐭𝐞𝐦𝐩𝐥𝐚𝐭𝐞 𝐜𝐨𝐯𝐞𝐫𝐬 𝐭𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐭𝐨𝐩𝐢𝐜𝐬
𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧
Chronic obstructive pulmonary disease (𝐂𝐎𝐏𝐃) is a group of lung diseases that cause airflow blockage and breathing-related problems.
𝐩𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞
COPD is more prevalent in developing countries, but it is also a growing problem in developed countries. In the United States, COPD is the third leading cause of death.
Forms of 𝐂𝐎𝐏𝐃
• Chronic bronchitis
• Emphysema
𝐏𝐚𝐭𝐡𝐨𝐩𝐡𝐲𝐬𝐢𝐨𝐥𝐨𝐠𝐲
In normal lungs, air flows freely in and out of the bronchi and alveoli. However, in people with COPD, the airflow is blocked. This can be caused by inflammation of the airways, mucus production, or damage to the air sacs.
𝐑𝐢𝐬𝐤 𝐅𝐚𝐜𝐭𝐨𝐫𝐬
There are several risk factors for COPD, including smoking, air pollution, and genetics. Smoking is the most common risk factor for COPD. Smoking is responsible for about 80% of COPD cases. Air pollution, particularly indoor air pollution from cooking and burning fuels, can also increase the risk of COPD. Genetics can also play a role in COPD. People with a family history of COPD are more likely to develop the disease.
𝐜𝐚𝐮𝐬𝐞𝐬
The main causes of COPD are smoking and air pollution. Smoking damages the lungs and makes it difficult to breathe
𝐒𝐭𝐚𝐠𝐞𝐬
• Stage 1
• Stage 2
• Stage 3
.
𝐒𝐲𝐦𝐩𝐭𝐨𝐦𝐬
The most common symptoms of COPD are:
• Shortness of breath
• Cough
• Wheezing
• Chest tightness
• Fatigue
𝐂𝐨𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬
COPD can lead to several complications, including:
• Anemia
• Right-sided heart failure
• Muscle weakness
• Lung infections
• Bone thinning
• Collapsed lungs
𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐦𝐞𝐭𝐡𝐨𝐝𝐬
COPD is diagnosed with a spirometry test, which measures how much air a person can exhale.
𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐎𝐩𝐭𝐢𝐨𝐧𝐬
There is no cure for COPD, but there are treatments that can help manage the symptoms and slow the progression of the disease. Treatment options include:
• Bronchodilators
• Antibiotics
• Supplemental oxygen
• Vaccination
𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐯𝐞 𝐌𝐞𝐭𝐡𝐨𝐝𝐬
The best way to prevent COPD is to avoid smoking and air pollution. Several lifestyle changes can help reduce the risk of COPD, such as eating a healthy diet and exercising regularly.
Visit our site for more animated templates
𝗵𝘁𝘁𝗽𝘀://𝘄𝘄𝘄.𝗿𝘅𝘀𝗹𝗶𝗱𝗲𝘀.𝗰𝗼𝗺
RxSlides PowerPoint icons and illustrations related to 𝐂𝐎𝐏𝐃 will help you customize the content of this editable presentation according to your content and audience interest.
Chronic obstructive pulmonary disease (COPD)- Preeti sharmaEducate with smile
COPD is a type of obstructive lung disease and related conditions. it is very helpful presentation to you about information of COPD.
It includes all things that is definition, causes, symptoms, pathophysiology, diagnostic evaluation, types, treatment and role of nurses for COPD patient.
COPD, EMPHYSEMA, CHRONIC BRONCHITIS,LUNG DISEASE, OBSTRUCTIVE LING DISEASE, PHYSIOLOGY, KINGS COLLEGE,DPT DEPARTMENT ALL necessary information regarding lung disease which you should know
COPD (Chronic Obstructive Pulmonary Disease), also known as emphysema or chronic bronchitis, is a prevalent lung disease characterized by restricted airflow and breathing issues, often caused by damage or clogging of the lungs. This presentation includes: COPD, its causes, risk factors, symptoms, diagnosis, treatment, management, etc. For more information, please contact us: 9779030507.
Understanding COPD_ A Brief Overview.pdfParulHospital
One frequent lung condition that causes breathing difficulties and reduced airflow is chronic obstructive pulmonary disease, or COPD. It is sometimes referred to as chronic bronchitis or emphysema.Phlegm buildup or lung damage can occur in individuals with COPD. The symptoms include fatigue, wheezing, coughing, and occasionally phlegm. Even the best hospitals in Halol and other Indian cities indicate that COPD is a serious issue and it needs to be taken seriously.
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent respiratory symptoms and airflow limitation. The main symptoms include dyspnea, cough, and sputum production. COPD is caused by exposure to inhaled irritants, most often cigarette smoke, leading to chronic inflammation and structural changes in the lungs.
The predominant form of COPD is chronic bronchitis, which involves chronic cough and sputum production for at least 3 months per year for 2 consecutive years. This is associated with inflammation and eventual thickening of the bronchial tubes. Emphysema is another form of COPD characterized by permanent enlargement of airspaces and destruction of lung parenchyma.
The airflow limitation in COPD is due to a combination of parenchymal destruction (emphysema) and small airways disease (chronic bronchitis). The obstruction is generally progressive and irreversible. Diagnosis is based on symptoms, exposure history, and spirometry showing irreversible airflow limitation.
COPD treatment aims to reduce symptoms, improve exercise tolerance, prevent exacerbations, and slow disease progression. Smoking cessation is essential. Medications used include bronchodilators and inhaled steroids. Supplemental oxygen may be required in advanced disease. Exacerbations are treated with antibiotics, oral steroids, and other supportive therapies. Patients often have decreased quality of life and COPD is a leading cause of mortality worldwide.
Etiopathogenesis and pharmacotherapy of COPD
a. the pathophysiology of selected disease states and the rationale for drug therapy;
b. the therapeutic approach to management of these diseases;
c. the controversies in drug therapy;
d. the importance of preparation of individualised therapeutic plans based on diagnosis;
e. needs to identify the patient-specific parameters relevant in initiating drug therapy,
and monitoring therapy (including alternatives, time-course of clinical and laboratory
indices of therapeutic response and adverse effects);
f. describe the pathophysiology of selected disease states and explain the rationale for
drug therapy;
g. summarise the therapeutic approach to management of these diseases including
reference to the latest available evidence;
h. discuss the controversies in drug therapy;
i. discuss the preparation of individualised therapeutic plans based on diagnosis; and
j. identify the patient-specific parameters relevant in initiating drug therapy, and
monitoring therapy (including alternatives, time-course of clinical and laboratory
indices of therapeutic response and adverse effects).
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Thank you for selecting our 𝐂𝐎𝐏𝐃 PPT
This medical PowerPoint template about 𝐂𝐎𝐏𝐃
You can download our template by visiting our website:
https://www.rxslides.com/product/copd-powerpoint-template
copy and paste this URL into the browser and download the full editable template.
This 𝐂𝐎𝐏𝐃 animated template is designed by RxSlides, a medical professional team covering the following topics about 𝐂𝐎𝐏𝐃
𝐓𝐡𝐞 𝐭𝐞𝐦𝐩𝐥𝐚𝐭𝐞 𝐜𝐨𝐯𝐞𝐫𝐬 𝐭𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐭𝐨𝐩𝐢𝐜𝐬
𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧
Chronic obstructive pulmonary disease (𝐂𝐎𝐏𝐃) is a group of lung diseases that cause airflow blockage and breathing-related problems.
𝐩𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞
COPD is more prevalent in developing countries, but it is also a growing problem in developed countries. In the United States, COPD is the third leading cause of death.
Forms of 𝐂𝐎𝐏𝐃
• Chronic bronchitis
• Emphysema
𝐏𝐚𝐭𝐡𝐨𝐩𝐡𝐲𝐬𝐢𝐨𝐥𝐨𝐠𝐲
In normal lungs, air flows freely in and out of the bronchi and alveoli. However, in people with COPD, the airflow is blocked. This can be caused by inflammation of the airways, mucus production, or damage to the air sacs.
𝐑𝐢𝐬𝐤 𝐅𝐚𝐜𝐭𝐨𝐫𝐬
There are several risk factors for COPD, including smoking, air pollution, and genetics. Smoking is the most common risk factor for COPD. Smoking is responsible for about 80% of COPD cases. Air pollution, particularly indoor air pollution from cooking and burning fuels, can also increase the risk of COPD. Genetics can also play a role in COPD. People with a family history of COPD are more likely to develop the disease.
𝐜𝐚𝐮𝐬𝐞𝐬
The main causes of COPD are smoking and air pollution. Smoking damages the lungs and makes it difficult to breathe
𝐒𝐭𝐚𝐠𝐞𝐬
• Stage 1
• Stage 2
• Stage 3
.
𝐒𝐲𝐦𝐩𝐭𝐨𝐦𝐬
The most common symptoms of COPD are:
• Shortness of breath
• Cough
• Wheezing
• Chest tightness
• Fatigue
𝐂𝐨𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬
COPD can lead to several complications, including:
• Anemia
• Right-sided heart failure
• Muscle weakness
• Lung infections
• Bone thinning
• Collapsed lungs
𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐦𝐞𝐭𝐡𝐨𝐝𝐬
COPD is diagnosed with a spirometry test, which measures how much air a person can exhale.
𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐎𝐩𝐭𝐢𝐨𝐧𝐬
There is no cure for COPD, but there are treatments that can help manage the symptoms and slow the progression of the disease. Treatment options include:
• Bronchodilators
• Antibiotics
• Supplemental oxygen
• Vaccination
𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐯𝐞 𝐌𝐞𝐭𝐡𝐨𝐝𝐬
The best way to prevent COPD is to avoid smoking and air pollution. Several lifestyle changes can help reduce the risk of COPD, such as eating a healthy diet and exercising regularly.
Visit our site for more animated templates
𝗵𝘁𝘁𝗽𝘀://𝘄𝘄𝘄.𝗿𝘅𝘀𝗹𝗶𝗱𝗲𝘀.𝗰𝗼𝗺
RxSlides PowerPoint icons and illustrations related to 𝐂𝐎𝐏𝐃 will help you customize the content of this editable presentation according to your content and audience interest.
Chronic obstructive pulmonary disease (COPD)- Preeti sharmaEducate with smile
COPD is a type of obstructive lung disease and related conditions. it is very helpful presentation to you about information of COPD.
It includes all things that is definition, causes, symptoms, pathophysiology, diagnostic evaluation, types, treatment and role of nurses for COPD patient.
COPD, EMPHYSEMA, CHRONIC BRONCHITIS,LUNG DISEASE, OBSTRUCTIVE LING DISEASE, PHYSIOLOGY, KINGS COLLEGE,DPT DEPARTMENT ALL necessary information regarding lung disease which you should know
COPD (Chronic Obstructive Pulmonary Disease), also known as emphysema or chronic bronchitis, is a prevalent lung disease characterized by restricted airflow and breathing issues, often caused by damage or clogging of the lungs. This presentation includes: COPD, its causes, risk factors, symptoms, diagnosis, treatment, management, etc. For more information, please contact us: 9779030507.
Understanding COPD_ A Brief Overview.pdfParulHospital
One frequent lung condition that causes breathing difficulties and reduced airflow is chronic obstructive pulmonary disease, or COPD. It is sometimes referred to as chronic bronchitis or emphysema.Phlegm buildup or lung damage can occur in individuals with COPD. The symptoms include fatigue, wheezing, coughing, and occasionally phlegm. Even the best hospitals in Halol and other Indian cities indicate that COPD is a serious issue and it needs to be taken seriously.
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent respiratory symptoms and airflow limitation. The main symptoms include dyspnea, cough, and sputum production. COPD is caused by exposure to inhaled irritants, most often cigarette smoke, leading to chronic inflammation and structural changes in the lungs.
The predominant form of COPD is chronic bronchitis, which involves chronic cough and sputum production for at least 3 months per year for 2 consecutive years. This is associated with inflammation and eventual thickening of the bronchial tubes. Emphysema is another form of COPD characterized by permanent enlargement of airspaces and destruction of lung parenchyma.
The airflow limitation in COPD is due to a combination of parenchymal destruction (emphysema) and small airways disease (chronic bronchitis). The obstruction is generally progressive and irreversible. Diagnosis is based on symptoms, exposure history, and spirometry showing irreversible airflow limitation.
COPD treatment aims to reduce symptoms, improve exercise tolerance, prevent exacerbations, and slow disease progression. Smoking cessation is essential. Medications used include bronchodilators and inhaled steroids. Supplemental oxygen may be required in advanced disease. Exacerbations are treated with antibiotics, oral steroids, and other supportive therapies. Patients often have decreased quality of life and COPD is a leading cause of mortality worldwide.
Etiopathogenesis and pharmacotherapy of COPD
a. the pathophysiology of selected disease states and the rationale for drug therapy;
b. the therapeutic approach to management of these diseases;
c. the controversies in drug therapy;
d. the importance of preparation of individualised therapeutic plans based on diagnosis;
e. needs to identify the patient-specific parameters relevant in initiating drug therapy,
and monitoring therapy (including alternatives, time-course of clinical and laboratory
indices of therapeutic response and adverse effects);
f. describe the pathophysiology of selected disease states and explain the rationale for
drug therapy;
g. summarise the therapeutic approach to management of these diseases including
reference to the latest available evidence;
h. discuss the controversies in drug therapy;
i. discuss the preparation of individualised therapeutic plans based on diagnosis; and
j. identify the patient-specific parameters relevant in initiating drug therapy, and
monitoring therapy (including alternatives, time-course of clinical and laboratory
indices of therapeutic response and adverse effects).
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2. Overview:
Chronic obstructive pulmonary disease, or COPD, refers to a
group of diseases that cause airflow blockage and breathing-
related problems.
Emphysema and chronic bronchitis are the two most common
conditions that contribute to COPD.
Other names:
Chronic obstructive lung disease (COLD)
chronic obstructive airway disease (COAD)
3.
4. Chronic bronchitis:
It is inflammation of the lining of the
bronchial tubes, which carry air to and from
the air sacs (alveoli) of the lungs. It's
characterized by daily cough and mucus
(sputum) production.
Emphysema:
It is a condition in which the alveoli at the end
of the smallest air passages (bronchioles) of
the lungs are destroyed as a result of
damaging exposure to cigarette smoke and
other irritating gases and particulate matter.
5. Prevelence:
According to WHO estimates, 65 million people have moderate to severe chronic
obstructive pulmonary disease (COPD). More than 3 million people died of COPD in
2005, which corresponds to 5% of all deaths globally. Most of the information available
on COPD prevalence, morbidity and mortality comes from high-income countries. Even
in those countries, accurate epidemiologic data on COPD are difficult and expensive to
collect. It is known that almost 90% of COPD deaths occur in low- and middle-income
countries.
In 2002 COPD was the fifth leading cause of death. Total deaths from COPD are
projected to increase by more than 30% in the next 10 years unless urgent action is
taken to reduce the underlying risk factors, especially tobacco use. Estimates show that
COPD becomes in 2030 the third leading cause of death worldwide.
6. Common Causes and risk factors of
COPD:
COPD is most likely to result from:
•Smoking:
About 85 to 90 percent of all COPD cases are
caused by cigarette smoking. When a
cigarette burns, it creates more than 7,000
chemicals, many of which are harmful. The
toxins in cigarette smoke weaken your lungs'
defense against infections, narrow air
passages, cause swelling in air tubes and
destroy air sacs—all contributing factors for
COPD.
7. •Your Environment:
What a person breathe every day at work, home and outside can play a
role in developing COPD. Long-term exposure to air pollution,
secondhand smoke and dust, fumes and chemicals (which are often
work-related) can cause COPD.
•Alpha-1 Deficiency:
A small number of people have a rare form of COPD called alpha-1
deficiency-related emphysema. This form of COPD is caused by a
genetic (inherited) condition that affects the body's ability to produce a
protein (Alpha-1) that protects the lungs.
8. Risk Factors for COPD:
Things that can make you more likely to get
COPD include:
• Smoking: This is the most common cause of
COPD.
• Asthama: chances are even higher if someone
having asthma and you smoke.
• Age: Most people are 40 or older when their
symptoms start up.
• Certain jobs: If someone job puts him/her
around dust, chemical fumes, or vapors, the
lungs can get damaged. Damage can also come
from prolonged exposure to air pollution.
• Infections: If someone had lots of respiratory
infections in childhood, that have a greater
chance of COPD in adulthood.
9. COPD
peripheral airway
inflammation and narrowing
of the airways.
airflow limitation and the
destruction and loss of alveoli
airflow limitation and leads
to decreased gas transfer
capacity
development of fibrosis within
the airway and presence of
secretions or exudates
Reduced airflow on exhalation
leads to air trapping, resulting
in reduced inspiratory capacity
breathlessness (also known as
dyspnoea) on exertion and
reduced exercise capacity
Pathophysiology
Abnormalities in gas transfer occur due to reduced airflow/ventilation
and as a result of loss of alveolar structure and pulmonary vascular bed.
Low blood oxygen levels (hypoxaemia) and raised blood carbon
dioxide levels (hypercapnia) result from impaired gas transfer and can
worsen as the disease inevitably progresses.
10. Symptoms:
• A cough that doesn't go away
• Coughing up lots of mucus
• Shortness of breath, especially when you’re physically active
• Wheezing or squeaking when you breathe
• Tightness in your chest
• Frequent ccolds or flu
• Blue fingernails
• Low energy
• Losing weight without trying (in later stages)
• Swallon ankel, feet, or legs
11.
12. Stage 1 Symptoms are mild and often missed but the damage to the
lungs begins. Symptoms include:
• Persistent cough, which could be dry or accompanied with
mucus that is clear, white, yellow or green
• Shortness of breath on exertion
Stage 2 • Persistent cough with mucus that may be worse in the morning
• Shortness of breath even with mild routine activity
• Wheezing on exertion
• Disturbed sleep
• Fatigue
Symptoms of stages
13. Stage 3 Stage III has a bigger impact on the quality of life. The symptoms in
stage III worsen considerably. Additional symptoms include:
• Frequent respiratory tract infections
• Swelling of the ankles, feet and legs
• Tightness in the chest
• Trouble taking a deep breath
• Wheezing and other breathing issues when doing basic tasks
Stage 4 This is the final stage of COPD. Occurs after years of continuous damage to
the lungs. Patients have worsened symptoms of stage III and frequent flare
ups that are sometimes fatal. Patients have a very poor quality of
life. Symptoms include:
• Barrel shaped chest
• Constant wheezing
• Being out of breath
• delirium
• Increased heart rate/heartbeat
• Loss of appetite and weight
• Increased blood pressure
14. Diagnosis
COPD is commonly misdiagnosed. Many people who
have COPD may not be diagnosed until the disease is advanced.
The most common test is called spirometry.
You’ll breathe into a large, flexible tube that’s connected to a
machine called a spirometer. It’ll measure how much air your lungs
can hold and how fast you can blow air out of them.
15. The doctor may order other tests to rule out other lungs problem, such as
asthma or heart failure.
These might include:
• More lung function tests
• Chest X-rays that can help rule out emphysema, other lung problems, or heart faliure
• CT scan, which uses several X-rays to create a detailed picture of your lungs and can
tell the doctor if you need surgery or if you have lungs cancer
• Arterial blood gas test, which measures how well your lungs are bringing in oxygen
and taking out carbon dioxide
• Laboratory tests to determine the cause of your symptoms or rule out
other conditions, like the genetic disorder alpha-1-antitrypsin (AAT) deficiency
16. Treatment:
Many people with COPD have mild forms of the disease for which little therapy is
needed other than smoking cessation. Even for more advanced stages of disease,
effective therapy is available that can control symptoms, slow progression, reduce
your risk of complications and exacerbations, and improve your ability to lead an
active life.
Quitting smoking
The most essential step in any treatment plan for COPD is to quit all smoking.
Stopping smoking can keep COPD from getting worse and reducing your ability to
breathe.
17. Medications:
Several kinds of medications are used to treat the symptoms and complications of COPD. You may
take some medications on a regular basis and others as needed.
Bronchodilators
Bronchodilators are medications that usually come in inhalers relax the muscles around your airways.
This can help relieve coughing and shortness of breath and make breathing easier. Depending on the
severity of your disease, you may need a short-acting bronchodilator before activities, a long-acting
bronchodilator that you use every day or both.
Examples of short-acting
bronchodilators include:
• Albuterol (ProAir HFA, Ventolin
HFA, others)
• Ipratropium (Atrovent HFA)
• Levalbuterol (Xopenex)
Examples of long-acting
bronchodilators include:
• Aclidinium (Tudorza Pressair)
• Arformoterol (Brovana)
• Formoterol (Perforomist)
18. Inhaled steroids
Inhaled corticosteroid medications can reduce airway inflammation and help prevent
exacerbations. Side effects may include bruising, oral infections and hoarseness.
These medications are useful for people with frequent exacerbations of COPD.
Examples of inhaled steroids include:
• Fluticasone (Flovent HFA)
• Budesonide (Pulmicort Flexhaler)
Combination inhalers
Some medications combine bronchodilators and inhaled steroids.
Examples of these combination inhalers include:
• Fluticasone and vilanterol (Breo Ellipta)
• Fluticasone, umeclidinium and vilanterol (Trelegy Ellipta)
• Formoterol and budesonide (Symbicort)
19. • Oral steroids or steroid inhalers
• Medication to clear and thin the mucus, and clear the airway
• Antibiotics for infection
• Pulmonary rehabilitation
• Oxygen therapy
• Surgery in severe cases, including a lung transplant may be required
• Breathing exercises
20. Strategies for managing COPD include:
• Vaccinations: People with COPD have an increased risk of
complications of flu and pnemonia. It is crucial to have up-to-date
vaccinations for these diseases.
• Physical activity: Regular physical activity can help a person
manage their COPD symptoms.
• Dietary changes: Improving the diet may help delay the progression
of COPD and reduce the risk of complications, such as weight loss
and fatigue.
22. Nutritional Guidelines:
Choose complex carbohydrates, such as whole-grain bread and pasta, fresh fruits and
vegetables.
• Limit simple carbohydrates, including table sugar, candy, cake and regular soft
drinks.
• Eat 20 to 30 grams of fiber each day, from items such as bread, pasta, nuts, seeds,
fruits and vegetables. Eat a good source of protein at least twice a day to help
maintain strong respiratory muscles. Good choices include milk, eggs, cheese, meat,
fish, poultry, nuts and dried beans or peas.
• Choose mono- and poly-unsaturated fats, which do not contain cholesterol. These
are fats that are often liquid at room temperature and come from plant sources, such as
canola, safflower and corn oils.
• Limit foods that contain trans fats and saturated fat. For example, butter, lard, fat
and skin from meat, hydrogenated vegetable oils, shortening, fried foods, cookies,
crackers and pastries.
23. Vitamins and minerals
Many people find taking a general-purpose multivitamin helpful. Often, people with COPD
take steroids. Long-term use of steroids may increase your need for calcium. Consider
taking calcium supplements. Look for one that includes vitamin D. Calcium carbonate or
calcium citrate are good sources of calcium.
Sodium
Too much sodium may cause edema (swelling) that may increase blood pressure. If edema
or high blood pressure are health problems for you, talk with your doctor about how much
sodium you should be eating each day.
Fluids
Drinking plenty of water is important not only to keep you hydrated, but also to help keep
mucus thin for easier removal. Talk with your doctor about your water intake. A good goal
for many people is 6 to 8 glasses (8 fluid ounces each) daily.
26. References:
1. Agustí A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas
DA, Calverley PM, Wouters E, Crim C. Persistent systemic inflammation is associated with
poor clinical outcomes in COPD: a novel phenotype. PloS one. 2012 May 18;7(5):e37483.
2. https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/living-with-
copd/nutrition#:~:text=Eat%20a%20good%20source%20of,and%20low%2Dfat%20dairy%2
0products.
3. https://www.medicinenet.com/what_are_the_four_stages_of_copd/article.htm